Terry Clyburn
Orthopaedic Surgery · Houston, TXNPI 1811921059
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,350 of the $19,364 with a category attached, or 63.8%. Conformis, Inc. accounts for 61.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $18,626 and has fallen 99.9% since, to $15 in 2025.
Across 61 payments — averaging $317.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conformis, Inc.$12K
- Pacira Therapeutics, Inc.$7K
- Microport Orthopedics Inc$150
- Johnson & Johnson$92
- Maxx Orthopedics, Inc.$51
- Ferring Pharmaceuticals Inc.$38
- plus $104 from 5 others
Across 4 payments — averaging $1425.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Conformis, Inc.$6K
What the payments were for
- Consulting fees$4,67624%
- Speaking & faculty fees$12,35064%
- Travel & lodging$7364%
- Food & beverage$1,6028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conformis, Inc. | 13 | $11,822 |
| Pacira Therapeutics, Inc. | 32 | $7,107 |
| Microport Orthopedics Inc | 1 | $150 |
| Johnson & Johnson | 6 | $92 |
| Maxx Orthopedics, Inc. | 1 | $51 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Bioventus LLC | 2 | $37 |
| Stryker | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Ossur Americas, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hip$11,348
- Zilretta$6,519
- Identity Imprint Knee Replacement System$152
- Actera Hip Stem$152
- MPO Medial Pivot Knee$150
- iTotal, Identity CR$131
How this compares
$19,364 in reported general payments places this provider in the 75th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 199 | $2,224 |
| Celecoxib | 19 | $572 |
| Meloxicam | 53 | $192 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $74 |
| Tramadol Hcl | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Houston
- Stefan KreuzerHouston$6.2M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- Adam FreedhandHouston$1.8M
- Jeffrey KozakHouston$1.1M
- Travis HansonHouston$1M
- Thomas TanousHouston$698K
- Alan RechterHouston$605K
- Ugonna IhekweazuHouston$544K
- Darrell HansonHouston$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.